Deutsche Bank
ONCT

Deutsche Bank’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History

Deutsche Bank’s Portfolio ONCT Stock Details ONCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,202
Closed -$33K – 4389
2022
Q1 		$33K Sell
1,202
-143
-11% -$5.2K ﹤0.01% 3955
2021
Q4 		$61K Buy
1,345
+72
+6% +$4.84K ﹤0.01% 3896
2021
Q3 		$106K Sell
1,273
-2,046
-62% -$169K ﹤0.01% 3885
2021
Q2 		$315K Buy
+3,319
New +$394K ﹤0.01% 3517
2019
Q4 		– Hold
0
– – – 5184
2019
Q3 		– Sell
-463
Closed -$47.4K – 5371
2019
Q2 		$60K Sell
463
-1,257
-73% -$194K ﹤0.01% 4447
2019
Q1 		$288K Buy
1,720
+1,674
+3,639% +$250K ﹤0.01% 3783
2018
Q4 		$4K Sell
46
-36
-44% -$7.2K ﹤0.01% 5023
2018
Q3 		$18K Sell
82
-244
-75% -$586K ﹤0.01% 4958
2018
Q2 		$699K Buy
326
+205
+169% +$520K ﹤0.01% 3654
2018
Q1 		$300K Buy
+121
New +$270K ﹤0.01% 3989
2016
Q4 		– Sell
-52
Closed -$57K – 5122
2016
Q3 		$57K Buy
+52
New +$45.4K ﹤0.01% 4165
2016
Q1 		– Hold
0
– – – 5386
2015
Q4 		– Hold
0
– – – 5455
2014
Q3 		– Sell
-32
Closed -$60K – 6135
2014
Q2 		$60K Buy
32
+24
+300% +$47.5K ﹤0.01% 4842
2014
Q1 		$17K Buy
8
+4
+100% +$9.96K ﹤0.01% 4893
2013
Q4 		$8K Sell
4
-20
-83% -$45.7K ﹤0.01% 4940
2013
Q3 		$67K Sell
24
-26
-52% -$129K ﹤0.01% 4569
2013
Q2 		$461K Buy
+50
New +$385K ﹤0.01% 3226

Other funds holding ONCT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
QPW
Quantum Private Wealth Tampa, Florida $390M AUM 58.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
BJL
Brighton Jones LLC Seattle, Washington $2.37B AUM 16.36% 1-Year Est. Return

Deutsche Bank's ONCT Position: Q2 2022 in Review

Deutsche Bank sold out of Oncternal Therapeutics, Inc. Common Stock (ONCT) in Q2 2022, closing a stake of 1,202 shares — an estimated $33K sold.

Deutsche Bank first reported a position in ONCT in Q2 2013 and held it in 16 quarters. The position peaked at $699K in Q2 2018. 75 funds tracked by Wall St. Rank hold ONCT as of Q2 2022.

  • Deutsche Bank reported no remaining Oncternal Therapeutics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Deutsche Bank sold 1,202 Oncternal Therapeutics, Inc. Common Stock shares in Q2 2022, an estimated $33K.
  • Deutsche Bank first reported a position in Oncternal Therapeutics, Inc. Common Stock in Q2 2013 and held it in 16 quarters.
  • Deutsche Bank's Oncternal Therapeutics, Inc. Common Stock position peaked at $699K in Q2 2018.
  • 75 funds tracked by Wall St. Rank held Oncternal Therapeutics, Inc. Common Stock as of Q2 2022.

Based on Deutsche Bank's 13F filing for Q2 2022, filed 11 Aug 2022.